Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

Jon Sussex, Yan Feng, Jorge Mestre-Ferrandiz, Michele Pistollato, Marco Hafner, Peter Burridge, Jonathan Grant

ABSTRACT

BACKGROUND: Government- and charity-funded medical research and private sector research and development (R&D) are widely held to be complements. The only attempts to measure this complementarity so far have used data from the United States of America and are inevitably increasingly out of date. This study estimates the magnitude of the effect of government and charity biomedical and health research expenditure in the United Kingdom (UK), separately and in total, on subsequent private pharmaceutical sector R&D expenditure in the UK. METHODS: The results for this study are obtained by fitting an econometric vector error correction model (VECM) to time series for biomedical and health R&D expenditure in the UK for ten disease areas (including 'other') for the government, charity and private sectors. The VECM model describes the relationship between public (i.e. government and charities combined) sector expenditure, private sector expenditure and global pharmaceutical sales as a combination of a long-term equilibrium and short-term movements. RESULTS: There is a statistically significant complementary relationship between public biomedical and health research expenditure and private pharmaceutical R&D expenditure. A 1% increase in public sector expenditure is associated in the best-fit model with a 0.81% increase in private sector expenditure. Sensitivity analysis produces a similar and statistically significant result with a slightly smaller positive elasticity of 0.68. Overall, every additional £1 of public research expenditure is associated with an additional £0.83-£1.07 of private sector R&D spend in the UK; 44% of that additional private sector expenditure occurs within 1 year, with the remainder accumulating over decades. This spillover effect implies a real annual rate of return (in terms of economic impact) to public biomedical and health research in the UK of 15-18%. When combined with previous estimates of the health gain that results from public medical research in cancer and cardiovascular disease, the total rate of return would be around 24-28%. CONCLUSION: Overall, this suggests that government and charity funded research in the UK crowds in additional private sector R&D in the UK. The implied historical returns from UK government and charity funded investment in medical research in the UK compare favourably with the rates of return achieved on investments in the rest of the UK economy and are greatly in excess of the 3.5% real annual rate of return required by the UK government to public investments generally. More... »

PAGES

32

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12916-016-0564-z

DOI

http://dx.doi.org/10.1186/s12916-016-0564-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1011671285

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26908129


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1402", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Applied Economics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/14", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Economics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomedical Research", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Charities", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Financial Management", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Government", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Expenditures", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Econometric", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Private Sector", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Public Sector", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Research", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United Kingdom", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Office Of Health Economics", 
          "id": "https://www.grid.ac/institutes/grid.482825.1", 
          "name": [
            "RAND Europe, Cambridge, UK", 
            "Formerly, Office of Health Economics, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sussex", 
        "givenName": "Jon", 
        "id": "sg:person.01351514340.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351514340.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Office Of Health Economics", 
          "id": "https://www.grid.ac/institutes/grid.482825.1", 
          "name": [
            "Office of Health Economics, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Feng", 
        "givenName": "Yan", 
        "id": "sg:person.0723015016.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723015016.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Office Of Health Economics", 
          "id": "https://www.grid.ac/institutes/grid.482825.1", 
          "name": [
            "Office of Health Economics, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mestre-Ferrandiz", 
        "givenName": "Jorge", 
        "id": "sg:person.01351556637.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351556637.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Office Of Health Economics", 
          "id": "https://www.grid.ac/institutes/grid.482825.1", 
          "name": [
            "Formerly, Office of Health Economics, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pistollato", 
        "givenName": "Michele", 
        "id": "sg:person.0640155570.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640155570.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "RAND Europe", 
          "id": "https://www.grid.ac/institutes/grid.425785.9", 
          "name": [
            "RAND Europe, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hafner", 
        "givenName": "Marco", 
        "id": "sg:person.0756124517.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756124517.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of York", 
          "id": "https://www.grid.ac/institutes/grid.5685.e", 
          "name": [
            "Department of Economics, University of York, Heslington, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burridge", 
        "givenName": "Peter", 
        "id": "sg:person.07433773763.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07433773763.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "King's College London", 
          "id": "https://www.grid.ac/institutes/grid.13097.3c", 
          "name": [
            "Policy Institute at King\u2019s, King\u2019s College London, Strand Campus, WC2R 2LS, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grant", 
        "givenName": "Jonathan", 
        "id": "sg:person.01055471415.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055471415.15"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1214/aos/1176346801", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005460302"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1467-9892.1984.tb00381.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006526701"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1741-7015-12-99", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006565540", 
          "https://doi.org/10.1186/1741-7015-12-99"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0165-1765(97)00214-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006898116"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00191-007-0059-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008662835", 
          "https://doi.org/10.1007/s00191-007-0059-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00191-007-0059-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008662835", 
          "https://doi.org/10.1007/s00191-007-0059-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/s0266466600012421", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011322255"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/amiajnl-2011-000213", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031293266"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1465-7295.1995.tb01847.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031830107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1465-7295.1995.tb01847.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031830107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/1467-6451.00067", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042131484"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0304-4076(95)01753-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051002956"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/508314", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058786261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/ipe.1.25056140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058907717"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/icc/10.4.975", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059654576"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1162/0033553041502144", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063348973"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2307/1913236", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069640597"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074965672", 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00191-017-0524-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091048368", 
          "https://doi.org/10.1007/s00191-017-0524-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00191-017-0524-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091048368", 
          "https://doi.org/10.1007/s00191-017-0524-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/cbo9780511492327", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1098680657"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/0198774508.001.0001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1098730911"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "BACKGROUND: Government- and charity-funded medical research and private sector research and development (R&D) are widely held to be complements. The only attempts to measure this complementarity so far have used data from the United States of America and are inevitably increasingly out of date. This study estimates the magnitude of the effect of government and charity biomedical and health research expenditure in the United Kingdom (UK), separately and in total, on subsequent private pharmaceutical sector R&D expenditure in the UK.\nMETHODS: The results for this study are obtained by fitting an econometric vector error correction model (VECM) to time series for biomedical and health R&D expenditure in the UK for ten disease areas (including 'other') for the government, charity and private sectors. The VECM model describes the relationship between public (i.e. government and charities combined) sector expenditure, private sector expenditure and global pharmaceutical sales as a combination of a long-term equilibrium and short-term movements.\nRESULTS: There is a statistically significant complementary relationship between public biomedical and health research expenditure and private pharmaceutical R&D expenditure. A 1% increase in public sector expenditure is associated in the best-fit model with a 0.81% increase in private sector expenditure. Sensitivity analysis produces a similar and statistically significant result with a slightly smaller positive elasticity of 0.68. Overall, every additional \u00a31 of public research expenditure is associated with an additional \u00a30.83-\u00a31.07 of private sector R&D spend in the UK; 44% of that additional private sector expenditure occurs within 1 year, with the remainder accumulating over decades. This spillover effect implies a real annual rate of return (in terms of economic impact) to public biomedical and health research in the UK of 15-18%. When combined with previous estimates of the health gain that results from public medical research in cancer and cardiovascular disease, the total rate of return would be around 24-28%.\nCONCLUSION: Overall, this suggests that government and charity funded research in the UK crowds in additional private sector R&D in the UK. The implied historical returns from UK government and charity funded investment in medical research in the UK compare favourably with the rates of return achieved on investments in the rest of the UK economy and are greatly in excess of the 3.5% real annual rate of return required by the UK government to public investments generally.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12916-016-0564-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.3560719", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3957548", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1032885", 
        "issn": [
          "1741-7015"
        ], 
        "name": "BMC Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "name": "Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the United Kingdom", 
    "pagination": "32", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "379baa3a7fe38d157f494cfe7b82668269bc51191479f7b8de2366dea5cf901b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26908129"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101190723"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12916-016-0564-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1011671285"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12916-016-0564-z", 
      "https://app.dimensions.ai/details/publication/pub.1011671285"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:15", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000549.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs12916-016-0564-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12916-016-0564-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12916-016-0564-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12916-016-0564-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12916-016-0564-z'


 

This table displays all metadata directly associated to this object as RDF triples.

232 TRIPLES      21 PREDICATES      60 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12916-016-0564-z schema:about N07cdb0bd9b744d8b85cfb445a643654a
2 N319888fc1a184c4d91311a785bb14404
3 N47b441c7dce94dc49ac58e0e34900f95
4 N7aaade1a6f3d46618b646972bdc29462
5 N829c2ccc49ad4b7d8d8bc67fed7a3beb
6 N97bbd1a822ce451d9a40a06e064208c1
7 Na3de17c40b9948d4b7c43b6e8aa2a7a9
8 Nb5300df3c24649ae9e5b955312096b7b
9 Nc7fb762e0c2d413e8abe0d5d0d8042f6
10 Nc9177955778c4c34b22283a5794cac44
11 Nd860a995fa174e2b8a9f6bc12482f584
12 Ne5dbf2f64ac14f819277b65bfebe2568
13 anzsrc-for:14
14 anzsrc-for:1402
15 schema:author N694e6b071fd44687847f3151c4bcb68a
16 schema:citation sg:pub.10.1007/s00191-007-0059-3
17 sg:pub.10.1007/s00191-017-0524-6
18 sg:pub.10.1186/1741-7015-12-99
19 https://app.dimensions.ai/details/publication/pub.1074965672
20 https://doi.org/10.1016/0304-4076(95)01753-4
21 https://doi.org/10.1016/s0165-1765(97)00214-0
22 https://doi.org/10.1017/cbo9780511492327
23 https://doi.org/10.1017/s0266466600012421
24 https://doi.org/10.1086/508314
25 https://doi.org/10.1086/ipe.1.25056140
26 https://doi.org/10.1093/0198774508.001.0001
27 https://doi.org/10.1093/icc/10.4.975
28 https://doi.org/10.1111/1467-6451.00067
29 https://doi.org/10.1111/j.1465-7295.1995.tb01847.x
30 https://doi.org/10.1111/j.1467-9892.1984.tb00381.x
31 https://doi.org/10.1136/amiajnl-2011-000213
32 https://doi.org/10.1162/0033553041502144
33 https://doi.org/10.1214/aos/1176346801
34 https://doi.org/10.2307/1913236
35 schema:datePublished 2016-12
36 schema:datePublishedReg 2016-12-01
37 schema:description BACKGROUND: Government- and charity-funded medical research and private sector research and development (R&D) are widely held to be complements. The only attempts to measure this complementarity so far have used data from the United States of America and are inevitably increasingly out of date. This study estimates the magnitude of the effect of government and charity biomedical and health research expenditure in the United Kingdom (UK), separately and in total, on subsequent private pharmaceutical sector R&D expenditure in the UK. METHODS: The results for this study are obtained by fitting an econometric vector error correction model (VECM) to time series for biomedical and health R&D expenditure in the UK for ten disease areas (including 'other') for the government, charity and private sectors. The VECM model describes the relationship between public (i.e. government and charities combined) sector expenditure, private sector expenditure and global pharmaceutical sales as a combination of a long-term equilibrium and short-term movements. RESULTS: There is a statistically significant complementary relationship between public biomedical and health research expenditure and private pharmaceutical R&D expenditure. A 1% increase in public sector expenditure is associated in the best-fit model with a 0.81% increase in private sector expenditure. Sensitivity analysis produces a similar and statistically significant result with a slightly smaller positive elasticity of 0.68. Overall, every additional £1 of public research expenditure is associated with an additional £0.83-£1.07 of private sector R&D spend in the UK; 44% of that additional private sector expenditure occurs within 1 year, with the remainder accumulating over decades. This spillover effect implies a real annual rate of return (in terms of economic impact) to public biomedical and health research in the UK of 15-18%. When combined with previous estimates of the health gain that results from public medical research in cancer and cardiovascular disease, the total rate of return would be around 24-28%. CONCLUSION: Overall, this suggests that government and charity funded research in the UK crowds in additional private sector R&D in the UK. The implied historical returns from UK government and charity funded investment in medical research in the UK compare favourably with the rates of return achieved on investments in the rest of the UK economy and are greatly in excess of the 3.5% real annual rate of return required by the UK government to public investments generally.
38 schema:genre research_article
39 schema:inLanguage en
40 schema:isAccessibleForFree true
41 schema:isPartOf N3cdcbd13216a4330975073fb0fe48a24
42 N59482e86b3c74880ba08bdd3c3bf2b4d
43 sg:journal.1032885
44 schema:name Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the United Kingdom
45 schema:pagination 32
46 schema:productId N41385ac792b74f1dae46c59faddff9be
47 N46caff71306c42f8b08c7090cfac1907
48 Nb12e1818bab44291b644732c7044798d
49 Nd0c4236df340488dbfd8ba9daca494f9
50 Ne70b29279a7c4d2db1ee07e2fbe47183
51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011671285
52 https://doi.org/10.1186/s12916-016-0564-z
53 schema:sdDatePublished 2019-04-10T19:15
54 schema:sdLicense https://scigraph.springernature.com/explorer/license/
55 schema:sdPublisher N4a0cb8a618c44d23ae0c44e70cabc487
56 schema:url http://link.springer.com/10.1186%2Fs12916-016-0564-z
57 sgo:license sg:explorer/license/
58 sgo:sdDataset articles
59 rdf:type schema:ScholarlyArticle
60 N07cdb0bd9b744d8b85cfb445a643654a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Biomedical Research
62 rdf:type schema:DefinedTerm
63 N090b0773fe534be88fbe542468f346c6 rdf:first sg:person.07433773763.16
64 rdf:rest N495686c8e2a04eea85866bc37cb7afa0
65 N0b3004d4facf4bd6ab4bfaa58037dfb2 rdf:first sg:person.0640155570.04
66 rdf:rest Nc3898e45590a4eeca074507d1113b2a0
67 N319888fc1a184c4d91311a785bb14404 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Government
69 rdf:type schema:DefinedTerm
70 N3cdcbd13216a4330975073fb0fe48a24 schema:volumeNumber 14
71 rdf:type schema:PublicationVolume
72 N41385ac792b74f1dae46c59faddff9be schema:name dimensions_id
73 schema:value pub.1011671285
74 rdf:type schema:PropertyValue
75 N46caff71306c42f8b08c7090cfac1907 schema:name nlm_unique_id
76 schema:value 101190723
77 rdf:type schema:PropertyValue
78 N47b441c7dce94dc49ac58e0e34900f95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Public Sector
80 rdf:type schema:DefinedTerm
81 N495686c8e2a04eea85866bc37cb7afa0 rdf:first sg:person.01055471415.15
82 rdf:rest rdf:nil
83 N4a0cb8a618c44d23ae0c44e70cabc487 schema:name Springer Nature - SN SciGraph project
84 rdf:type schema:Organization
85 N59482e86b3c74880ba08bdd3c3bf2b4d schema:issueNumber 1
86 rdf:type schema:PublicationIssue
87 N694e6b071fd44687847f3151c4bcb68a rdf:first sg:person.01351514340.11
88 rdf:rest N834fe9eb06ff4bcf8bc3b560789fb922
89 N7aaade1a6f3d46618b646972bdc29462 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Charities
91 rdf:type schema:DefinedTerm
92 N829c2ccc49ad4b7d8d8bc67fed7a3beb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Financial Management
94 rdf:type schema:DefinedTerm
95 N834fe9eb06ff4bcf8bc3b560789fb922 rdf:first sg:person.0723015016.37
96 rdf:rest Nc2e7ef088a644a2d889d8fac01b99e1b
97 N97bbd1a822ce451d9a40a06e064208c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Research
99 rdf:type schema:DefinedTerm
100 Na3de17c40b9948d4b7c43b6e8aa2a7a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Models, Econometric
102 rdf:type schema:DefinedTerm
103 Nb12e1818bab44291b644732c7044798d schema:name pubmed_id
104 schema:value 26908129
105 rdf:type schema:PropertyValue
106 Nb5300df3c24649ae9e5b955312096b7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Neoplasms
108 rdf:type schema:DefinedTerm
109 Nc2e7ef088a644a2d889d8fac01b99e1b rdf:first sg:person.01351556637.67
110 rdf:rest N0b3004d4facf4bd6ab4bfaa58037dfb2
111 Nc3898e45590a4eeca074507d1113b2a0 rdf:first sg:person.0756124517.33
112 rdf:rest N090b0773fe534be88fbe542468f346c6
113 Nc7fb762e0c2d413e8abe0d5d0d8042f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Humans
115 rdf:type schema:DefinedTerm
116 Nc9177955778c4c34b22283a5794cac44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name United Kingdom
118 rdf:type schema:DefinedTerm
119 Nd0c4236df340488dbfd8ba9daca494f9 schema:name readcube_id
120 schema:value 379baa3a7fe38d157f494cfe7b82668269bc51191479f7b8de2366dea5cf901b
121 rdf:type schema:PropertyValue
122 Nd860a995fa174e2b8a9f6bc12482f584 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Health Expenditures
124 rdf:type schema:DefinedTerm
125 Ne5dbf2f64ac14f819277b65bfebe2568 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Private Sector
127 rdf:type schema:DefinedTerm
128 Ne70b29279a7c4d2db1ee07e2fbe47183 schema:name doi
129 schema:value 10.1186/s12916-016-0564-z
130 rdf:type schema:PropertyValue
131 anzsrc-for:14 schema:inDefinedTermSet anzsrc-for:
132 schema:name Economics
133 rdf:type schema:DefinedTerm
134 anzsrc-for:1402 schema:inDefinedTermSet anzsrc-for:
135 schema:name Applied Economics
136 rdf:type schema:DefinedTerm
137 sg:grant.3560719 http://pending.schema.org/fundedItem sg:pub.10.1186/s12916-016-0564-z
138 rdf:type schema:MonetaryGrant
139 sg:grant.3957548 http://pending.schema.org/fundedItem sg:pub.10.1186/s12916-016-0564-z
140 rdf:type schema:MonetaryGrant
141 sg:journal.1032885 schema:issn 1741-7015
142 schema:name BMC Medicine
143 rdf:type schema:Periodical
144 sg:person.01055471415.15 schema:affiliation https://www.grid.ac/institutes/grid.13097.3c
145 schema:familyName Grant
146 schema:givenName Jonathan
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055471415.15
148 rdf:type schema:Person
149 sg:person.01351514340.11 schema:affiliation https://www.grid.ac/institutes/grid.482825.1
150 schema:familyName Sussex
151 schema:givenName Jon
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351514340.11
153 rdf:type schema:Person
154 sg:person.01351556637.67 schema:affiliation https://www.grid.ac/institutes/grid.482825.1
155 schema:familyName Mestre-Ferrandiz
156 schema:givenName Jorge
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351556637.67
158 rdf:type schema:Person
159 sg:person.0640155570.04 schema:affiliation https://www.grid.ac/institutes/grid.482825.1
160 schema:familyName Pistollato
161 schema:givenName Michele
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640155570.04
163 rdf:type schema:Person
164 sg:person.0723015016.37 schema:affiliation https://www.grid.ac/institutes/grid.482825.1
165 schema:familyName Feng
166 schema:givenName Yan
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723015016.37
168 rdf:type schema:Person
169 sg:person.07433773763.16 schema:affiliation https://www.grid.ac/institutes/grid.5685.e
170 schema:familyName Burridge
171 schema:givenName Peter
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07433773763.16
173 rdf:type schema:Person
174 sg:person.0756124517.33 schema:affiliation https://www.grid.ac/institutes/grid.425785.9
175 schema:familyName Hafner
176 schema:givenName Marco
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756124517.33
178 rdf:type schema:Person
179 sg:pub.10.1007/s00191-007-0059-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008662835
180 https://doi.org/10.1007/s00191-007-0059-3
181 rdf:type schema:CreativeWork
182 sg:pub.10.1007/s00191-017-0524-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091048368
183 https://doi.org/10.1007/s00191-017-0524-6
184 rdf:type schema:CreativeWork
185 sg:pub.10.1186/1741-7015-12-99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006565540
186 https://doi.org/10.1186/1741-7015-12-99
187 rdf:type schema:CreativeWork
188 https://app.dimensions.ai/details/publication/pub.1074965672 schema:CreativeWork
189 https://doi.org/10.1016/0304-4076(95)01753-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051002956
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1016/s0165-1765(97)00214-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006898116
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1017/cbo9780511492327 schema:sameAs https://app.dimensions.ai/details/publication/pub.1098680657
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1017/s0266466600012421 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011322255
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1086/508314 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058786261
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1086/ipe.1.25056140 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058907717
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1093/0198774508.001.0001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1098730911
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1093/icc/10.4.975 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059654576
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1111/1467-6451.00067 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042131484
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1111/j.1465-7295.1995.tb01847.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1031830107
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1111/j.1467-9892.1984.tb00381.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1006526701
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1136/amiajnl-2011-000213 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031293266
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1162/0033553041502144 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063348973
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1214/aos/1176346801 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005460302
216 rdf:type schema:CreativeWork
217 https://doi.org/10.2307/1913236 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069640597
218 rdf:type schema:CreativeWork
219 https://www.grid.ac/institutes/grid.13097.3c schema:alternateName King's College London
220 schema:name Policy Institute at King’s, King’s College London, Strand Campus, WC2R 2LS, London, UK
221 rdf:type schema:Organization
222 https://www.grid.ac/institutes/grid.425785.9 schema:alternateName RAND Europe
223 schema:name RAND Europe, Cambridge, UK
224 rdf:type schema:Organization
225 https://www.grid.ac/institutes/grid.482825.1 schema:alternateName Office Of Health Economics
226 schema:name Formerly, Office of Health Economics, London, UK
227 Office of Health Economics, London, UK
228 RAND Europe, Cambridge, UK
229 rdf:type schema:Organization
230 https://www.grid.ac/institutes/grid.5685.e schema:alternateName University of York
231 schema:name Department of Economics, University of York, Heslington, UK
232 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...